...
首页> 外文期刊>Cell death & disease. >Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells
【24h】

Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells

机译:线粒体复合物I的抑制触发线粒体依赖性ROS的增加,从而导致黑素瘤细胞的坏死病和肥大病

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Inhibition of complex I (CI) of the mitochondrial respiratory chain by BAY 87-2243 (‘BAY’) triggers death of BRAFV600E melanoma cell lines and inhibits in vivo tumor growth. Here we studied the mechanism by which this inhibition induces melanoma cell death. BAY treatment depolarized the mitochondrial membrane potential (Δ ψ ), increased cellular ROS levels, stimulated lipid peroxidation and reduced glutathione levels. These effects were paralleled by increased opening of the mitochondrial permeability transition pore (mPTP) and stimulation of autophagosome formation and mitophagy. BAY-induced cell death was not due to glucose shortage and inhibited by the antioxidant α -tocopherol and the mPTP inhibitor cyclosporin A. Tumor necrosis factor receptor-associated protein 1 (TRAP1) overexpression in BAY-treated cells lowered ROS levels and inhibited mPTP opening and cell death, whereas the latter was potentiated by TRAP1 knockdown. Knockdown of autophagy-related 5 (ATG5) inhibited the BAY-stimulated autophagosome formation, cellular ROS increase and cell death. Knockdown of phosphatase and tensin homolog-induced putative kinase 1 (PINK1) inhibited the BAY-induced Δ ψ depolarization, mitophagy stimulation, ROS increase and cell death. Dynamin-related protein 1 (Drp1) knockdown induced mitochondrial filamentation and inhibited BAY-induced cell death. The latter was insensitive to the pancaspase inhibitor z-VAD-FMK, but reduced by necroptosis inhibitors (necrostatin-1, necrostatin-1s)) and knockdown of key necroptosis proteins (receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and mixed lineage kinase domain-like (MLKL)). BAY-induced cell death was also reduced by the ferroptosis inhibitor ferrostatin-1 and overexpression of the ferroptosis-inhibiting protein glutathione peroxidase 4 (GPX4). This overexpression also inhibited the BAY-induced ROS increase and lipid peroxidation. Conversely, GPX4 knockdown potentiated BAY-induced cell death. We propose a chain of events in which: (i) CI inhibition induces mPTP opening and Δ ψ depolarization, that (ii) stimulate autophagosome formation, mitophagy and an associated ROS increase, leading to (iii) activation of combined necroptotic/ferroptotic cell death.
机译:BAY 87-2243('BAY')对线粒体呼吸链复合物I(CI)的抑制会触发BRAF V600E 黑色素瘤细胞系死亡,并抑制体内肿瘤的生长。在这里,我们研究了这种抑制作用诱导黑素瘤细胞死亡的机制。 BAY处理使线粒体膜电位(Δψ)去极化,增加细胞ROS水平,刺激脂质过氧化并降低谷胱甘肽水平。这些作用与线粒体通透性过渡孔(mPTP)的增加开口和自噬体形成和线粒体的刺激相平行。 BAY诱导的细胞死亡不是由于葡萄糖不足引起的,而是由抗氧化剂α-生育酚和mPTP抑制剂环孢菌素A抑制。在BAY处理的细胞中肿瘤坏死因子受体相关蛋白1(TRAP1)的过表达降低了ROS水平并抑制了mPTP的开放和细胞死亡,而后者通过TRAP1敲低而增强。抑制自噬相关5(ATG5)抑制了BAY刺激的自噬体形成,细胞ROS增加和细胞死亡。磷酸酶和张力蛋白同源物诱导的假定激酶1(PINK1)的抑制抑制BAY诱导的Δψ去极化,线粒体刺激,ROS增加和细胞死亡。动力相关蛋白1(Drp1)敲低诱导线粒体丝化并抑制BAY诱导的细胞死亡。后者对泛半胱天冬酶抑制剂z-VAD-FMK不敏感,但被坏死性抑制剂(necrostatin-1,necrostatin-1s)和关键坏死性蛋白(与受体相互作用的丝氨酸/苏氨酸蛋白激酶1(RIPK1)和混合谱系激酶域样(MLKL))。受铁蛋白抑制因子ferrostatin-1和铁蛋白抑制蛋白谷胱甘肽过氧化物酶4(GPX4)的过表达也减少了BAY诱导的细胞死亡。这种过表达也抑制了BAY诱导的ROS增加和脂质过氧化。相反,GPX4敲低增强了BAY诱导的细胞死亡。我们提出了一系列事件,其中:(i)CI抑制诱导mPTP开放和Δψ去极化,(ii)刺激自噬体形成,线粒体吞噬和相关的ROS升高,从而导致(iii)活化的坏死性/肥大性细胞死亡。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号